Fund Overview
13F Filed: 2026-02-13As of 2025 Q4, Idg-Accel China Capital Gp Ii Associates Ltd. manages $25M in reported 13F assets , holds 2 positions with +100.00% top-10 concentration , and delivered a 1-year return of +140.93% on its disclosed equity portfolio. Filing 13F reports since 2020.
Activity Summary — 2025 Q4
Top Buys
| Stock | % Impact |
|---|---|
| CRCL CIRCLE INTERNET.. | +100.00% |
Top Sells
| Stock | % Impact |
|---|---|
| No major sells detected | |
Activity Summary
Sector Allocation Trends
Holdings Analysis
Positions Dynamics
Portfolio Analytics — Latest
IDG-Accel China Capital GP II Associates Ltd. risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.
Tracking institutional benchmark deviation
Best Strategy vs. Benchmarks
Strategy Backtester: IDG-Accel China Capital GP II Associates Ltd.
Replicate top holdings performance • Compare vs benchmarks • Optimize N
Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.
Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.
⏱ Run Backtest
Liquid Glass Edition
👆 Click the button to launch tickers!
Backtesting IDG-Accel China Capital GP II Associates Ltd.'s top 10 holdings against SPY identified 13 underperformance periods. Worst drawdown: 2021-09 – 2022-04 (-79.7% vs SPY, 8 quarters).
The ticker-level breakdown shows how each of IDG-Accel China Capital GP II Associates Ltd.'s top holdings contributed to portfolio returns quarter by quarter. Current top positions: CRCL (100.0%) .
Frequently Asked Questions
What does Idg-Accel China Capital Gp Ii Associates Ltd. invest in?
What is Idg-Accel China Capital Gp Ii Associates Ltd.'s AUM?
How concentrated is Idg-Accel China Capital Gp Ii Associates Ltd.'s portfolio?
How to track Idg-Accel China Capital Gp Ii Associates Ltd. 13F filings?
Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.